Role of corticotropin-releasing factor, vasopressin and the autonomic nervous system in learning and memory.
暂无分享,去创建一个
[1] Y. Ohgami,et al. Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats , 1997, Behavioural Brain Research.
[2] J. Verbalis,et al. In vitro release of vasopressin and oxytocin from rat median eminence tissue. , 1986, Neuroendocrinology.
[3] D. Wied,et al. Neuropeptides: Effects on paradoxical sleep and theta rhythm in rats , 1978, Pharmacology Biochemistry and Behavior.
[4] Q. Pittman,et al. Release of vasopressin and oxytocin by paraventricular stimulation in rats. , 1990, The American journal of physiology.
[5] M. Nijsen,et al. The Role of the CRH Type 1 Receptor in Autonomic Responses to Corticotropin-Releasing Hormone in the Rat , 2000, Neuropsychopharmacology.
[6] F. Luft,et al. Vasopressin: mechanism of central cardiovascular action in conscious rats. , 1986, Journal of cardiovascular pharmacology.
[7] M. Whitnall. Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons. , 1989, Neuroendocrinology.
[8] T. Lovenberg,et al. Characterization of Corticotropin‐releasing Factor Receptor Subtypes a , 1996 .
[9] M. Fanselow,et al. Conditional and unconditional components of post-shock freezing , 1980, The Pavlovian journal of biological science.
[10] E. Zimmerman,et al. Magnocellular hypothalamic projections to the lower brain stem and spinal cord of the rat. Immunocytochemical evidence for predominance of the oxytocin-neurophysin system compared to the vasopressin-neurophysin system. , 1980, Neuroendocrinology.
[11] L. Fisher. Central autonomic modulation of cardiac baroreflex by corticotropin-releasing factor. , 1989, The American journal of physiology.
[12] S. Maier,et al. The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress * , 1998 .
[13] F. Bloom,et al. Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory? , 1983, Behavioural Brain Research.
[14] S. Lightman,et al. Haemodynamic effects of arginine-vasopressin microinjections into the nucleus tractus solitarius: A comparative study of vasopressin, a selective vasopressin receptor agonist and antagonist, and oxytocin , 1984, Neuroscience Letters.
[15] M. Brody,et al. Regional hemodynamic responses to central administration of corticotropin-releasing factor (CRF) , 1988, Brain Research.
[16] E. D. De Souza,et al. Corticotropin-releasing factor receptors: an overview. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[17] D. Wied,et al. Central Vasopressin Impairs the Baroreceptor Heart Rate Reflex in Conscious Rats , 1990, Journal of cardiovascular pharmacology.
[18] J. Koolhaas,et al. Conditioned neuroendocrine and cardiovascular stress responsiveness accompanying behavioral passivity and activity in aged and in young rats , 1992, Physiology & Behavior.
[19] N. Kalin,et al. Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems , 1990, Brain Research.
[20] M. Sakanaka,et al. Corticotropin releasing factor‐like immunoreactivity in the rat brain as revealed by a modified cobalt‐glucose oxidase‐diaminobenzidine method , 1987, The Journal of comparative neurology.
[21] P. Sawchenko. Evidence for differential regulation of corticotropin-releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus , 1987, Brain Research.
[22] F. Antoni. Novel ligand specificity of pituitary vasopressin receptors in the rat. , 1984, Neuroendocrinology.
[23] A. Steffens,et al. University of Groningen The Hypothalamus, Intrinsic Connections and Outflow Pathways to the Endocrine System in Relation to the Control of Feeding and Metabolism Luiten, , 2002 .
[24] S. Korte,et al. Central Actions of Corticotropin-Releasing Hormone (CRH) on Behavioral, Neuroendocrine, and Cardiovascular Regulation: Brain Corticoid Receptor Involvement , 1993, Hormones and Behavior.
[25] W. Young,et al. Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature. , 1994, Endocrinology.
[26] E. De Souza,et al. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] W. Vale,et al. Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. , 1982, Endocrinology.
[28] R. Quirion,et al. Potential neurotrophic factors in the mammalian central nervous system: functional significance in the developing and aging brain. , 1990, International review of neurobiology.
[29] Craig W. Berridge,et al. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? , 1990, Brain Research Reviews.
[30] E. Tribollet,et al. Vasopressin and oxytocin receptors in the central nervous system. , 1996, Critical reviews in neurobiology.
[31] X. Wang,et al. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress. , 1995, Neuroendocrinology.
[32] P. Kamphuis,et al. Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the rat. , 2000, European journal of pharmacology.
[33] W. Vale,et al. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. , 1982, Endocrinology.
[34] W. Vale,et al. Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. , 1996, Brain research. Molecular brain research.
[35] L. Fisher,et al. Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate , 1983, Regulatory Peptides.
[36] G. Kovacs,et al. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures , 1986, Brain Research.
[37] D. Gibbs. Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress. , 1984, Life sciences.
[38] J. L. Martínez,et al. Modulation of memory storage by treatments affecting peripheral catecholamines , 1982 .
[39] S. Henriksen,et al. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. , 1986, Neuroendocrinology.
[40] L. Fisher,et al. Central nervous effects of CRF and angiotensin II on cardiac output in conscious rats. , 1990, Journal of applied physiology.
[41] M. Joëls,et al. Arginine8-vasopressin enhances the responses of lateral septal neurons in the rat to excitatory amino acids and fimbria-fornix stimuli , 1984, Brain Research.
[42] J. Borrell,et al. Inhibitory avoidance deficit following short-term adrenalectomy in the rat: the role of adrenal catecholamines. , 1983, Behavioral and neural biology.
[43] H. Ohata,et al. Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1 , 1998, Neuroscience Letters.
[44] A. Budzikowski,et al. Central ANP attenuates pressor responses to central AVP in WKY and SHR , 1991, Brain Research Bulletin.
[45] J. Burbach,et al. Vasopressin and oxytocin. Their presence in the central nervous system and their functional significance in brain processes related to behaviour and memory. , 1986, Acta endocrinologica. Supplementum.
[46] D. Wied,et al. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats. , 1991, Endocrinology.
[47] T. Gray,et al. Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat , 1987, The Journal of comparative neurology.
[48] J. Coote,et al. Role of vasopressin in sympathetic response to paraventricular nucleus stimulation in anesthetized rats. , 1994, The American journal of physiology.
[49] T. Gray,et al. Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function , 1986, Regulatory Peptides.
[50] N. Ling,et al. The antagonistic effect of corticotropin-releasing factor on pentobarbital in rats , 1986, Brain Research.
[51] C. A. Marsan,et al. Neuronal plasticity and memory formation , 1982 .
[52] B. J. Cole. 7 – Corticotropin-Releasing Factor, Stress, and Animal Behavior , 1991 .
[53] T. Bliss,et al. Long‐lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path , 1973, The Journal of physiology.
[54] N. Murakami,et al. The central role of corticotrophin‐releasing factor (CRF‐41) in psychological stress in rats. , 1993, The Journal of physiology.
[55] Brown Mr.,et al. Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. , 1985 .
[56] J. Slangen,et al. Plasma catecholamine, corticosterone and glucose responses to repeated stress in rats: Effect of interstressor interval length , 1990, Physiology & Behavior.
[57] G. Feuerstein,et al. Cardiovascular effects of centrally administered vasopressin in conscious and anesthetized rats , 1985, Neuropeptides.
[58] T. Lovenberg,et al. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. , 1995, Endocrinology.
[59] Y. Taché,et al. Intracerebroventricular CRF inhibits cold restraint-induced c-fos expression in the dorsal motor nucleus of the vagus and gastric erosions in rats , 1996, Brain Research.
[60] M. Nijsen,et al. Vagal Activation in Novelty-Induced Tachycardia During the Light Phase in the Rat , 1998, Physiology & Behavior.
[61] E. Tribollet,et al. Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography , 1988, Brain Research.
[62] E. B. Souza. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders , 1995, Psychoneuroendocrinology.
[63] D. Gallager,et al. Autoradiographic Localization of CRF1 and CRF2 Binding Sites in Adult Rat Brain , 1997, Neuropsychopharmacology.
[64] S. Lightman,et al. Differential regulation of hypothalamic pituitary corticotropin releasing hormone receptors during development of adjuvant-induced arthritis in the rat. , 1997, The Journal of endocrinology.
[65] I. Merchenthaler,et al. Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord , 1983, Brain Research.
[66] M. Nijsen,et al. Conditioned fear-induced tachycardia in the rat: vagal involvement. , 1998, European journal of pharmacology.
[67] J. Herman,et al. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. , 1995, Neuroendocrinology.
[68] G. Tsujimoto,et al. Effects of Arginine-Vasopressin Fragment 4–9 on Rodent Cholinergic Systems , 1999, Pharmacology Biochemistry and Behavior.
[69] M. Joëls,et al. Amino acid neurotransmission between fimbria-fornix fibers and neurons in the lateral septum of the rat: A microiontophoretic study , 1984, Experimental Neurology.
[70] Y. Du,et al. Function and molecular basis of action of vasopressin 4-8 and its analogues in rat brain. , 1998, Progress in brain research.
[71] B. Roozendaal,et al. University of Groningen Differential effect of lesioning of the central amygdala on the bradycardiac and behavioral response of the rat in relation to conditioned social and solitary stress , 2017 .
[72] R. Ader,et al. Retention of a passive avoidance response as a function of the intensity and duration of electric shock , 1972 .
[73] J. Haywood,et al. Sympathetic nervous system activation by glutamate injections into the paraventricular nucleus , 1992, Brain Research.
[74] D. Wied. Peptides and behavior. , 1977 .
[75] J. D. McGaugh. Memory--a century of consolidation. , 2000, Science.
[76] C. Kilts,et al. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[77] L. Mahan,et al. Extrapituitary expression of the rat V1b vasopressin receptor gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[78] D. Wied,et al. Time-related memory effects of vasopressin analogues in rats , 1986, Pharmacology Biochemistry and Behavior.
[79] G. Koob,et al. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats , 1994, Physiology & Behavior.
[80] D. R. Britton. Stress-Related Behavioral Effects of Corticotropin-Releasing Factor , 1989 .
[81] G. Croiset,et al. Differential effects of DGAVP on acquisition and extinction of active avoidance behavior , 1991, Peptides.
[82] E. Freis,et al. Prophylactic approach to hypertensive diseases , 1979 .
[83] L. Swanson,et al. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. , 1983, Neuroendocrinology.
[84] Z. Mo,et al. Effects of vasopressin and angiotensin II on neurones in the rat dorsal motor nucleus of the vagus, in vitro. , 1992, The Journal of physiology.
[85] S. Foote,et al. Distribution of corticotropin‐releasing‐factor‐like immunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): An immunohistochemical study , 1988, The Journal of comparative neurology.
[86] G. Kovacs,et al. Facilitation of memory consolidation by vasopressin: Mediation by terminals of the dorsal noradrenergic bundle? , 1979, Brain Research.
[87] M. Opp,et al. Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[88] W. Vale,et al. Corticotropin-releasing factor: a physiologic regulator of adrenal epinephrine secretion , 1985, Brain Research.
[89] M. Wayner,et al. Corticotrophin‐releasing factor produces a long‐lasting enhancement of synaptic efficacy in the hippocampus , 1998, The European journal of neuroscience.
[90] T. Gray,et al. The amygdala: corticotropin-releasing factor, steroids, and stress. , 1996, Critical reviews in neurobiology.
[91] R. Wan,et al. Changes in heart rate and body temperature during passive avoidance behavior in rats , 1990, Physiology & Behavior.
[92] G. Kovacs,et al. Dose-dependent action of corticosteroids on brain serotonin content and passive avoidance behavior , 1977, Hormones and Behavior.
[93] D. Wied. Long Term Effect of Vasopressin on the Maintenance of a Conditioned Avoidance Response in Rats , 1971, Nature.
[94] J. Koolhaas,et al. Anxiolytics and stress-induced behavioural and cardiac responses: a study of diazepam and ipsapirone (TVX Q 7821). , 1990, European journal of pharmacology.
[95] D. Hebb. Textbook of psychology , 1958 .
[96] T. Gray,et al. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat , 1992, Peptides.
[97] Q. Pittman,et al. Vasopressin antagonist in nucleus tractus solitarius/vagal area reduces pressor and tachycardia responses to paraventricular nucleus stimulation in rats , 1985, Neuroscience Letters.
[98] L. Fisher,et al. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats. , 1991, Journal of the autonomic nervous system.
[99] T. Sugimoto,et al. Molecular cloning and characterization of rat V1b vasopressin receptor: evidence for its expression in extra-pituitary tissues. , 1995, Biochemical and biophysical research communications.
[100] R. F. Kirby,et al. Central oxytocin systems may mediate a cardiovascular response to acute stress in rats. , 1989, The American journal of physiology.
[101] C. Nemeroff,et al. Stress, Neuropeptides, and Systemic Disease , 1991 .
[102] P. Sawchenko,et al. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[103] G. Gillies,et al. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin , 1982, Nature.
[104] A. Sahgal,et al. Failure of vasopressin to enhance memory in a passive avoidance task in rats , 1982, Neuroscience Letters.
[105] F. Bloom,et al. Vasopressor receptor antagonist prevents behavioural effects of vasopressin , 1981, Nature.
[106] Y. Taché,et al. Neuropeptides and Stress , 2012, Hans Selye Symposia on Neuroendocrinology and Stress.
[107] R. Bartus,et al. The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.
[108] A. K. Johnson,et al. Blood pressure and heart rate responses to microinjection of vasopressin into the nucleus tractus solitarius region of the rat , 1982, Neuropharmacology.